4D Molecular Therapeutics, Inc.

8-K Other events Jul 20, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jun 29, 2026 8-K Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Results of operations (earnings release) Mar 18, 2026 8-K Unregistered sale of equity Jan 26, 2026 8-K Results of operations (earnings release); Director or officer change Jan 7, 2026 8-K Other events Dec 10, 2025 8-K Director or officer change Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Nov 7, 2025 8-K Results of operations (earnings release); Other events Nov 6, 2025 8-K Entered a material agreement Oct 31, 2025 8-K Director or officer change; Amended charter or bylaws Oct 2, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Director or officer change; Other events Jul 2, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 28, 2025 8-K Other events Feb 10, 2025 8-K Results of operations (earnings release); Other events Jan 10, 2025 8-K Unregistered sale of equity Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Other events Sep 18, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure Jul 23, 2024 8-K Other events Jul 17, 2024 8-K Entered a material agreement Jun 7, 2024 8-K Shareholder vote results May 24, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024